Overview

Etiology of the Platelet-Cancer Metastatic Pathway - A Study of Inflammatory Markers, Platelet Characteristics and Metastatic Surrogates in Cancer Patients and Controls

Status:
Unknown status

Trial end date:
2016-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this research study is to understand if platelets in the blood become more active during cancer and specially advanced stages of cancer, in the future the investigators want to see if reducing platelet activity can improve survival in advanced cancer.

Phase:

N/A

Details

Lead Sponsor:

Sinai Hospital of Baltimore

Treatments:

Everolimus
Letrozole
Sirolimus